Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with stage III or IV pancreatic ductal adenocarcinoma

Autor: Stubbe, Benjamin E., Madsen, Poul H., Larsen, Anders C., Krarup, Henrik B., Pedersen, Inge S., Hansen, Carsten P., Johansen, Julia S., Henriksen, Stine D., Thorlacius-Ussing, Ole

Publikováno v: In Pancreatology August 2023 23(5):512-521

Promoter hypermethylation of SFRP1 as a prognostic and predictive blood-based biomarker in patients with stage IV pancreatic ductal adenocarcinoma

Autor: Stubbe, Benjamin E., Henriksen, Stine D., Madsen, Poul H., Larsen, Anders C., Krarup, Henrik B., Pedersen, Inge S., Johansen, Julia S., Hansen, Carsten P., Thorlacius-Ussing, Ole

Publikováno v: Stubbe, B E, Henriksen, S D, Madsen, P H, Larsen, A C, Krarup, H B, Pedersen, I S, Johansen, J S, Hansen, C P & Thorlacius-Ussing, O 2022, ' Promoter hypermethylation of SFRP1 as a prognostic and predictive blood-based biomarker in patients with stage IV pancreatic ductal adenocarcinoma. ', Cancer Research, vol. 82, no. Suppl. 22, B047 . https://doi.org/10.1158/1538-7445.PANCA22-B047

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::d299368171c01138a8d6466e84cee0f9
https://vbn.aau.dk/da/publications/6fa1f184-a81e-489e-8469-072cb10937e5